Financial statements Medical Innovation
Balance sheet data of MEDICAL INNOVATION
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 65 000,00 | 65 000,00 | 65 000,00 | 65 000,00 | 377 493,58 | 380 928,89 |
| A. Fixed assets | 60 000,00 | 60 000,00 | 60 000,00 | 60 000,00 | 369 444,00 | 369 444,00 |
| B. Current assets | 5 000,00 | 5 000,00 | 5 000,00 | 5 000,00 | 8 049,58 | 11 484,89 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 65 000,00 | 65 000,00 | 65 000,00 | 65 000,00 | 377 493,58 | 380 928,89 |
| A. Equity | 21 496,43 | 18 065,83 | 13 238,81 | 13 140,67 | 1 249,44 | -38 999,60 |
| B. Liabilities and provisions for liabilities | 43 503,57 | 46 934,17 | 51 761,19 | 51 859,33 | 376 244,14 | 419 928,49 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.